The ClinicianThe ClinicianКлиницист1818-83382412-8775Publishing House ABV Press17910.17650/1818-8338-2015-1-30-36ORIGINAL INVESTIGATIONSОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕSUBCLINICAL INTERSTITIAL PULMONARY INJURY IN RHEUMATOID ARTHRITISСУБКЛИНИЧЕСКАЯ ФОРМА ИНТЕРСТИЦИАЛЬНОГО ПОРАЖЕНИЯ ЛЕГКИХ ПРИ РЕВМАТОИДНОМ АРТРИТЕBestaevD. V.БестаевД. В.Russian Federationdavidbestaev@rambler.ruBozhyevaL. A.БожьеваЛ. А.Russian FederationVolkovA. V.ВолковА. В.Russian FederationNovikovA. A.НовиковА. А.Russian FederationGlukhovaS. I.ГлуховаС. И.Russian FederationNasonovE. L.НасоновЕ. Л.Russian FederationV.A. Nasonova Research Institute of RheumatologyФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»34A Kashirskoe Shosse, Moscow, 115522, RussiaРоссия, 115522, Москва, Каширское шоссе, 34А150120159130361505201515052015Copyright ©; 2015, Bestaev D.V., Bozhyeva L.A., Volkov A.V., Novikov A.A., Glukhova S.I., Nasonov E.L.Copyright ©; 2015, Бестаев Д.В., Божьева Л.А., Волков А.В., Новиков А.А., Глухова С.И., Насонов Е.Л.2015Bestaev D.V., Bozhyeva L.A., Volkov A.V., Novikov A.A., Glukhova S.I., Nasonov E.L.Бестаев Д.В., Божьева Л.А., Волков А.В., Новиков А.А., Глухова С.И., Насонов Е.Л.https://creativecommons.org/licenses/by/4.0https://klinitsist.abvpress.ru/Klin/article/view/179rheumatoid arthritissubclinical interstitial pulmonary injuryhigh-resolution computed tomographyexternal respiratory functionlung diffusing capacitycytokinesanti-cyclic citrullinated peptide antibodiesrheumatoid factorinterleukinseotaxinревматоидный артрит, субклиническая форма интерстициального поражения легких, компьютерная томография высокого разрешения, функция внешнего дыхания, диффузионная способность легких, цитокины, антитела к циклическому цитруллинированному пептиду, ревматоид[1. Насонов Е.Л. Ревматоидный артрит как общемедицинская проблема. Терапевтческий архив 2004;76(5):5–7. [Nasonov E.L. Rheumatoid arthritis as a general medical problem. Terapevticheskiy arhiv = Therapeutic Archive 2004;76(5):5–7. (In Russ.)].Насонов Е.Л. Ревматоидный артрит как общемедицинская проблема. Терапевтческий архив 2004;76(5):5–7. [Nasonov E.L. Rheumatoid arthritis as a general medical problem. Terapevticheskiy arhiv = Therapeutic Archive 2004;76(5):5–7. (In Russ.)].][2. Насонов Е.Л., Чичасова Н.В. Рациональная терапия ревматоидного артрита. М.: Миклош, 2010. [Nasonov E.L., Chichasova N.V. Rational therapy of rheumatoid arthritis. Moscow: Miklosh, 2010. (In Russ.)].Насонов Е.Л., Чичасова Н.В. Рациональная терапия ревматоидного артрита. М.: Миклош, 2010. [Nasonov E.L., Chichasova N.V. Rational therapy of rheumatoid arthritis. Moscow: Miklosh, 2010. (In Russ.)].][3. Jurik A.G., Davidsen D., Graudal H. Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients. A radiological and clinical study. Scand J Rheumatol 1982;11(4):217–24.Jurik A.G., Davidsen D., Graudal H. Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients. A radiological and clinical study. Scand J Rheumatol 1982;11(4):217–24.][4. Dawson J.K., Fewins H.E., Desmond J. et al. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 2001;56(8):622–7.Dawson J.K., Fewins H.E., Desmond J. et al. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 2001;56(8):622–7.][5. Bongartz T., Nannini C., Medina-Velasquez Y.F. et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 2010;62(6): 1583–91.Bongartz T., Nannini C., Medina-Velasquez Y.F. et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 2010;62(6): 1583–91.][6. Suzuki A., Ohosone Y., Obana M. et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 1994;21(1):33–6.Suzuki A., Ohosone Y., Obana M. et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 1994;21(1):33–6.][7. Мазуров В.И., Богданов А.Н. Диагностика и лечение поражений легких у больных ревматоидным артритом. Научнопрактическая ревматология 2003;(1):52–6. [Mazurov V.I., Bogdanov A.N. Diagnostics and treatment of lung lesions of patients with rheumatoid arthritis. Nauchno-prakticheskaya revmatologiya = Scientific and Practical Rheumatology 2003;(1):52–6. (In Russ.)].Мазуров В.И., Богданов А.Н. Диагностика и лечение поражений легких у больных ревматоидным артритом. Научнопрактическая ревматология 2003;(1):52–6. [Mazurov V.I., Bogdanov A.N. Diagnostics and treatment of lung lesions of patients with rheumatoid arthritis. Nauchno-prakticheskaya revmatologiya = Scientific and Practical Rheumatology 2003;(1):52–6. (In Russ.)].][8. Bernscherer G., Karabelyos C., Tarjan Z. The pulmonological manifestations of rheumatoid arthritis (in Hungarian). Orv Hetil 2008;149(29):1355–61.Bernscherer G., Karabelyos C., Tarjan Z. The pulmonological manifestations of rheumatoid arthritis (in Hungarian). Orv Hetil 2008;149(29):1355–61.][9. Saadia M. Interstitial lung disease in rheumatoid arthritis: an update on diagnosis and management. Intern J Clin Rheumatol 2012;7(3):297–308.Saadia M. Interstitial lung disease in rheumatoid arthritis: an update on diagnosis and management. Intern J Clin Rheumatol 2012;7(3):297–308.][10. Gochuico B.R., Avila N.A., Chow C.K. et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 2008;168(2):159–66.Gochuico B.R., Avila N.A., Chow C.K. et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 2008;168(2):159–66.][11. Ascherman D.P. Interstitial lung disease in rheumatoid arthritis. Curr Rheumatol Rep 2010;12(5):363–9.Ascherman D.P. Interstitial lung disease in rheumatoid arthritis. Curr Rheumatol Rep 2010;12(5):363–9.][12. Gizinski A.M., Mascolo M., Loucks J.L. et al. Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA. Clin Rheumatol 2009;28(5):611–3.Gizinski A.M., Mascolo M., Loucks J.L. et al. Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA. Clin Rheumatol 2009;28(5):611–3.][13. Reynisdottir G., Karimi R., Joshua V. et al. Structural changes and antibody enrichment in the lungs are early features of anticitrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 2014;66(1):31–9.Reynisdottir G., Karimi R., Joshua V. et al. Structural changes and antibody enrichment in the lungs are early features of anticitrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 2014;66(1):31–9.][14. Demoruelle M.K., Weisman M.H., Derber P.L. et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012;64(6):1756–61.Demoruelle M.K., Weisman M.H., Derber P.L. et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012;64(6):1756–61.][15. Jones R.S., Meade F. A theoretical and experimental analysis of anomalies in the estimation of pulmonary diffusing capacity by the single breath method. Q J Exp Physiol Cogn Med Sci 1961;46:131–43.Jones R.S., Meade F. A theoretical and experimental analysis of anomalies in the estimation of pulmonary diffusing capacity by the single breath method. Q J Exp Physiol Cogn Med Sci 1961;46:131–43.][16. Miller M.R., Hankinson J., Brusasco V. et al.; ATS/ERS Task Force. Standardization of spirometry. Eur Resp J 2005;26(2):319–38.Miller M.R., Hankinson J., Brusasco V. et al.; ATS/ERS Task Force. Standardization of spirometry. Eur Resp J 2005;26(2):319–38.][17. Chen J., Shi Y., Wang X. et al. Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease. Clin Dev Immunol 2013;2013:406927.Chen J., Shi Y., Wang X. et al. Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease. Clin Dev Immunol 2013;2013:406927.][18. Liote H. Pulmonary manifestation of rheumatoid arthritis. Rev Mal Respir 2008;25(8):973–88.Liote H. Pulmonary manifestation of rheumatoid arthritis. Rev Mal Respir 2008;25(8):973–88.][19. Biederer J., Schnabel A., Muhle C. et al. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol 2004;14(2):272–80.Biederer J., Schnabel A., Muhle C. et al. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol 2004;14(2):272–80.][20. Kim E.J., Elicker B.M., Maldonado F. et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010;35(6):1322–8.Kim E.J., Elicker B.M., Maldonado F. et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010;35(6):1322–8.][21. Kim E.J., Collard H.R., King T.E. Jr. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009;136(5): 1397–405.Kim E.J., Collard H.R., King T.E. Jr. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009;136(5): 1397–405.][22. Hamblin M.J., Horton M.R. Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma. Pulm Med 2011; 2011:872120.Hamblin M.J., Horton M.R. Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma. Pulm Med 2011; 2011:872120.][23. Wynn T.A. Fibrotic disease and the T(H)1/ T(H)2 paradigm. Nat Rev Immunol 2004;4(8):583–94.Wynn T.A. Fibrotic disease and the T(H)1/ T(H)2 paradigm. Nat Rev Immunol 2004;4(8):583–94.][24. Ramalingam T.R., Pesce J.T., Sheikh F. et al. Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat Immunol 2008;9(1):25–33.Ramalingam T.R., Pesce J.T., Sheikh F. et al. Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat Immunol 2008;9(1):25–33.][25. Lupardus P.J., Birnbaum M.E., Garcia K.C. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL13Ralpha2. Structure 2010;18(3):332–42.Lupardus P.J., Birnbaum M.E., Garcia K.C. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL13Ralpha2. Structure 2010;18(3):332–42.][26. Wilson M.S., Elnekave E., Mentink-Kane M. et al. IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airwayhyperreactivity, and fibrosis in mice. J Clin Invest 2007;117(10):2941–51.Wilson M.S., Elnekave E., Mentink-Kane M. et al. IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airwayhyperreactivity, and fibrosis in mice. J Clin Invest 2007;117(10):2941–51.][27. Simonian P.L., Roark C.L., Wehrmann F. et al. Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. J Immunol 2009;182(1):657–65.Simonian P.L., Roark C.L., Wehrmann F. et al. Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. J Immunol 2009;182(1):657–65.][28. Wilson M.S., Madala S.K., Ramalingam T.R. et al. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 2010;207(3):535–52.Wilson M.S., Madala S.K., Ramalingam T.R. et al. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 2010;207(3):535–52.][29. Strieter R.M., Belperio J.A., Keane M.P. CXC chemokines in vascular remodeling related to pulmonary fibrosis. Am J Respir Cell Mol Biol 2003;29(3 Suppl):S67–9.Strieter R.M., Belperio J.A., Keane M.P. CXC chemokines in vascular remodeling related to pulmonary fibrosis. Am J Respir Cell Mol Biol 2003;29(3 Suppl):S67–9.]